Fundz

Arialys Therapeutics Appoints Dr. Sankalp Gokhale as Chief Medical Officer

PRIVATEOct 22, 2024

Position

Chief Medical Officer

Company

Arialys Therapeutics

Sankalp Gokhale
sgokhale@arialysrx.com
La JollaBiotechnologyHealth CareTherapeutics

Description

Arialys Therapeutics announced the appointment of Dr. Sankalp “Sam” Gokhale, a U.S. board-certified neurologist with extensive clinical practice and pharmaceutical industry experience, as its new Chief Medical Officer

Quick answer

Arialys Therapeutics Appoints Dr. Sankalp Gokhale as Chief Medical Officer (October 22, 2024). Arialys Therapeutics is based in La Jolla, California, United States.

Who is the new Chief Medical Officer at Arialys Therapeutics?
Arialys Therapeutics named Sankalp Gokhale Chief Medical Officer, announced October 22, 2024.
What did Arialys Therapeutics announce on October 22, 2024?
Arialys Therapeutics announced the appointment of Dr. Sankalp “Sam” Gokhale, a U.S. board-certified neurologist with extensive clinical practice and pharmaceutical industry experience, as its new Chief Medical Officer
What does Arialys Therapeutics do?
Arialys Therapeutics is developing new precision medicines to specifically block pathogenic autoantibodies in the brain, aiming to expand treatment possibilities for neuropsychiatric disorders driven by autoimmune...
Where is Arialys Therapeutics based?
Arialys Therapeutics is based in La Jolla, California, United States.
Which similar companies made leadership changes around the same time?
Parexel (October 22, 2024), LigaChem Biosciences (October 23, 2024), HuidaGene Therapeutics (October 21, 2024) and RYNE Biotechnology (October 23, 2024) also announced leadership changes within 45 days of Arialys Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Arialys Therapeutics, and when

A new leader at Arialys Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Arialys Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Arialys Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Arialys Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Arialys Therapeutics

Location

La Jolla, California, United States

About

Arialys Therapeutics is developing new precision medicines to specifically block pathogenic autoantibodies in the brain, aiming to expand treatment possibilities for neuropsychiatric disorders driven by autoimmune disease. Founded to explore the latest discoveries in autoimmune neuropsychiatry, the company is advancing a novel approach based on the growing understanding that immune cells—not only in the body’s periphery but especially in the brain—can produce autoantibodies that cause severe neurological and psychiatric conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Arialys Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Sankalp
Likely contact at this company
••••••••@••••••••

See Sankalp's verified email →

Christy
Likely contact at this company
••••••••@••••••••

See Christy's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Arialys Therapeutics's next move

Learn about Strategic plan

Arialys Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.